These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28322463)

  • 61. The Mechanisms of Regulation of Aerobic Glycolysis (Warburg Effect) by Oncoproteins in Carcinogenesis.
    Kobliakov VA
    Biochemistry (Mosc); 2019 Oct; 84(10):1117-1128. PubMed ID: 31694508
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protein mislocalization: mechanisms, functions and clinical applications in cancer.
    Wang X; Li S
    Biochim Biophys Acta; 2014 Aug; 1846(1):13-25. PubMed ID: 24709009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy.
    Blasi F; Bruckmann C
    J Dev Biol; 2021 Oct; 9(4):. PubMed ID: 34698191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methionine metabolism: a window on carcinogenesis?
    Gatton-Umphress TL; Weber KA; Seidler NW
    Hosp Pract (Off Ed); 1993 Sep; 28(9A):83-5, 89-90. PubMed ID: 8408364
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oncogenes as therapeutic targets.
    Felsher DW
    Semin Cancer Biol; 2004 Feb; 14(1):1. PubMed ID: 14757530
    [No Abstract]   [Full Text] [Related]  

  • 66. GPRC5A: A potential tumor suppressor and oncogene.
    Acquafreda T; Soprano KJ; Soprano DR
    Cancer Biol Ther; 2009 May; 8(10):963-5. PubMed ID: 19593893
    [No Abstract]   [Full Text] [Related]  

  • 67. Functional and physical communication between oncoproteins and tumor suppressors.
    Prochownik EV
    Cell Mol Life Sci; 2005 Nov; 62(21):2438-59. PubMed ID: 16143828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Grainyhead-like transcription factors in cancer - Focus on recent developments.
    Kotarba G; Taracha-Wisniewska A; Wilanowski T
    Exp Biol Med (Maywood); 2020 Mar; 245(5):402-410. PubMed ID: 32008358
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New insights into tumor suppressors.
    Marques M; Sweet-Cordero A
    Genome Biol; 2008; 9(9):320. PubMed ID: 18828882
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identifying critical signaling molecules for the treatment of cancer.
    Arvanitis C; Bendapudi PK; Bachireddy P; Felsher DW
    Recent Results Cancer Res; 2007; 172():5-24. PubMed ID: 17607933
    [No Abstract]   [Full Text] [Related]  

  • 71. The "Z"-Shaped Brainstem-A Tale of Two Distinct Gene Mutations.
    Chatur C; Balani A; Mankad K
    Neurol India; 2022; 70(2):794-795. PubMed ID: 35532665
    [No Abstract]   [Full Text] [Related]  

  • 72. A tale of two Nortons.
    Skeels P
    Stud Hist Philos Sci; 2020 Oct; 83():28-35. PubMed ID: 32958278
    [No Abstract]   [Full Text] [Related]  

  • 73. A tale of a vegetative inflammatory umbilical plaque.
    Litaiem N; Boumaiza S; Jones M; Bacha T; Slouma M; Guetat S; Rammeh S; Zeglaoui F
    Int J Dermatol; 2020 Aug; 59(8):938-940. PubMed ID: 32060900
    [No Abstract]   [Full Text] [Related]  

  • 74. A Tale of Two Countries.
    Kumar V
    Ann Intern Med; 2017 Nov; 167(9):686. PubMed ID: 29114748
    [No Abstract]   [Full Text] [Related]  

  • 75. A Bicyclist's Tale.
    Min Z; Alvarez G; Rao S; Khoury F; Cheema T; Bhanot N; Bishop HS; Qvarnstrom Y; Sapp SGH; Cantey PT
    Clin Infect Dis; 2022 Sep; 75(4):729-731. PubMed ID: 36087346
    [No Abstract]   [Full Text] [Related]  

  • 76. Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.
    Momeny M; Zarrinrad G; Moghaddaskho F; Poursheikhani A; Sankanian G; Zaghal A; Mirshahvaladi S; Esmaeili F; Eyvani H; Barghi F; Sabourinejad Z; Alishahi Z; Yousefi H; Ghasemi R; Dardaei L; Bashash D; Chahardouli B; Dehpour AR; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Sci Rep; 2017 Jun; 7(1):4204. PubMed ID: 28646172
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The genetics and the molecular functions of the PREP1 homeodomain transcription factor.
    Purushothaman D; Blasi F
    Int J Dev Biol; 2018; 62(11-12):819-825. PubMed ID: 30604851
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
    Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ
    Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922
    [No Abstract]   [Full Text] [Related]  

  • 79. The emerging role of MEIS1 in cell proliferation and differentiation.
    Jiang M; Xu S; Bai M; Zhang A
    Am J Physiol Cell Physiol; 2021 Mar; 320(3):C264-C269. PubMed ID: 33296285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
    Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG
    Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.